Encouraged by a 2002 federal law, drugmakers have been making important changes in drug labeling to accommodate treatments for children, according to a Government Accountability Office report. In exchange for extended patent protection, many companies are conducting studies of their drugs to determine their appropriate use with children.

Related Summaries